Improvements to tiny body-on-a-chip devices could lead to next-generation pre-clinical testing of drug toxicity
Researchers at Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) in Japan have designed a small ‘body-on-a-chip’ device that can test the side effects of drugs s on human cells. The device solves some issues with current, similar microfluidic devices and offers promise for the next generation of pre-clinical drug tests.
The Integrated Heart/Cancer on a Chip (iHCC) was used to test the toxicity of the anti-cancer drug doxorubicin on heart cells. The researchers, led by iCeMS’s Ken-ichiro Kamei, found that, while the drug itself was not toxic to heart cells, a metabolite of the drug resulting from its interaction with cancer cells was.
The device is smaller than a microscope glass slide. It contains six tiny chambers; every two are connected by microchannels with a series of port inlets and valves. A pneumatic pump controls movement of fluid through the channels. Every two chambers and their separate microchannel system constitute one test bed. Three test beds in the device allow for the introduction of minor changes in each bed to simultaneously compare results.
The team first tested doxorubicin’s effects on heart cells and liver cancer cells cultured separately in small wells. The drug had the expected anti-cancer effect on the cancer cells without causing damage to the heart cells.
They then ran the test using the iHCC device. Heart cells were placed in one chamber while liver cancer cells were placed in the other. Doxorubicin was introduced into a cell culture medium circulating through a closed-loop system of microchannels that connects the two chambers, mimicking the blood’s circulatory system. In this way, the drug flows unidirectionally in a continuous loop through both chambers.
The team found signs of toxicity in both cancer and heart cells. They hypothesized that a compound, doxorubicinol, which is a metabolic byproduct of doxorubicin interacting with cancer cells, was causing the toxic effect.
To test this, they added doxorubicinol to heart cells and liver cancer cells cultured separately in small wells. It was toxic to the heart cells but not to the cancer cells.
When doxorubicin alone is added to the liver cancer cells, the amount of doxorubicinol produced is too small to be toxic to the heart cells. The team believes this is because the amount of cell culture medium needed for the well-based tests dilutes the metabolite.
In contrast, when doxorubicin is introduced into the iHCC, the metabolite is not diluted when moving through the microchannel circulation system because a smaller volume of cell culture is needed. As a result, the drug does have a toxic effect on the heart cells via its metabolite.
The device requires further improvements, but the study demonstrates how this design concept could be used to investigate the toxic side effects of anti-cancer drugs on heart cells well before expensive clinical trials. The study was published in the journal Royal Society of Chemistry Advances.
Learn more: Next-generation drug testing on chips
The Latest on: Body-on-a-chip
[google_news title=”” keyword=”body-on-a-chip” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- MacBook Air with M4 chip coming in 2025 with AI features, no major design changes expected: Mark Gurmanon May 3, 2024 at 6:00 pm
Apple is rumoured to introduce M4-equipped Macs in fall 2024, with new MacBook Air anticipated for spring 2025, emphasizing AI capabilities and performance enhancements, hinted Gurman.
- Maple Leafs' Timothy Liljegren: Chips in with helperon May 2, 2024 at 4:55 pm
Liljegren registered an assist and three hits in Thursday's 2-1 win over the Bruins in Game 6.
- Fifth victim's body recovered in Baltimore Key Bridge collapseon May 2, 2024 at 5:46 am
Salvage crews continue to remove wreckage from the Dali one month after the cargo ship collided with and caused the collapse of the Francis Scott Key Bridge on April 26, 2024 in Baltimore, Maryland. ( ...
- I spent a decade struggling with body image; now I’m 19 and still learning to love food and myselfon April 30, 2024 at 4:30 am
Isabella Counts, a UC Santa Cruz sophomore, has spent her life worrying about her weight and look. She put herself on diets as early as sixth grade. She is not sure she will ever fully overcome her ...
- AMD Q1 Earnings Preview: Profitability At Risk With Slower Chip Marketon April 30, 2024 at 2:45 am
Advanced Micro Devices faces growing competition in the processor market, particularly from Qualcomm's new Snapdragon Elite and Plus series chips. See why AMD stock is a Hold.
- Multi-billion-dollar chip incentive plan in the works: Reporton April 28, 2024 at 11:41 pm
A multi-billion-dollar incentive scheme for semiconductor manufacturing companies could be launched after the new government takes charge, according to a report by the Times of India. The results for ...
- Infinix GT 20 Pro launched with 144Hz AMOLED display, Dimensity 8200, dedicated gaming chipon April 27, 2024 at 10:09 pm
The Infinix GT 20 Pro gaming phone has gone official in Saudi Arabia. The successor to last year’s GT 10 Pro offers a refined version of the Cyber Mecha design, featuring a C-shaped RGB-light design.
- ICEA bats for chip design, manufacturing to be treated as strategic sectoron April 25, 2024 at 10:45 am
Industry body ICEA has recommended various measures, including encouraging large Indian corporates to invest in semiconductor design and treating chip design and manufacturing as a strategic sector, ...
- Nvidia's Moat Remains Unchallenged Despite Emerging Players' Advanced AI Chipson April 24, 2024 at 8:05 pm
Upstart's focus on AI-specific chip efficiency might outperform Nvidia’s broader approach. Read why NVDA stock is a Buy despite challenges.
- Bioelectronic chip detects vitamins C and D in saliva in under 20 minuteson April 24, 2024 at 9:39 am
Researchers at the University of São Paulo (USP) in Brazil have developed a bioelectronic chip that simultaneously detects vitamins C and D in body fluids. It is flexible and easy to see and can be ...
via Google News and Bing News